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Abstract
Purpose To establish the effect of systemic
oxidative stress on the pathogenesis of
keratoconus by measuring serum total
oxidant status (TOS) and total antioxidant
status (TAS) in patients with keratoconus.
Methods Twenty-five patients with
keratoconus (keratoconus group) and 25
age–sex-matched healthy subjects (control
group) were enrolled in the study. Exclusion
criteria were smoking habit, history of any
other corneal pathology, systemic disease or
inflammation, and current antioxidant or
anti-inflammatory therapies. All participants
underwent a detailed ophthalmological
examination and corneal topography. Serum
samples were obtained from all participants.
Oxidative stress markers (TAS and TOS)
were measured using a commercial kit and
oxidative stress index (OSI) was calculated.
Results The study comprised 25 patients
with keratoconus (mean age of 26.4±1.7 years)
and 25 healthy control subjects (mean age of
26.6±1.7 years) (P40.05). The serum TOS and
OSI values were significantly higher in
patients with keratoconus compared with
those of the controls (P¼ 0.036 and 0.037,
respectively). However, serum TAS did not
show significant difference between the
keratoconus and control groups (P¼ 0.497).
Conclusions The higher levels of serum
oxidant status and OSI in patients with
keratoconus suggest that systemic oxidative
stress might be involved in the pathogenesis
of keratoconus.
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Introduction
Keratoconus is an ectatic corneal disorder
characterized by progressive stromal thinning
and irregular astigmatism that occurs in young
adults1,2 Major clinical findings are focal scarring,
breaks in Bowman’s layer, and iron deposits
within the epithelium.2 Although keratoconus is
defined as a non-inflammatory corneal disease
and the molecular pathophysiology of
keratoconus continues to be elucidated, recent
studies suggest that a combination of genetic and
environmental risk factors, such as eye rubbing,
atopy, inflammation, and oxidative stress, play a
role in the pathogenesis.1–3
Cornea as a transparent tissue absorbs most
of the ultraviolet (UV) light entering the eye and
UV is an important environmental stress factor
that creates cytotoxic free radicals.4 It could be
suggested that the cornea is exposed to free
radicals that lead to cellular damage by reacting
with proteins, DNA, and membrane
phospholipids. In the healthy cornea, a number
of defensive mechanisms such as superoxide
dismutase, catalase, glutathione peroxidase, and
glutathione reductase are present to eliminate
oxidative byproducts.4,5 However, keratoconic
corneas have accumulation of cytotoxic
byproducts (such as superoxides, hydrogen
peroxide, and hydroxyl radicals) and
abnormalities in antioxidant defense
mechanisms.6–8 More recently, corneal thinning
in the keratoconus has been found to be
associated with increase in tissue proteinase
activities and decrease in proteinase inhibitor
levels induced by oxidant products.9
Free radicals are produced in metabolic and
physiological processes, and harmful oxidative
reactions may occur in organisms.10 Organisms
are protected against oxidative stress via
enzymatic and non-enzymatic antioxidative
mechanisms.10 Under normal conditions, a
delicate balance exists between rates of free
radical formation and their removal by
antioxidant enzymes and molecules.
Oxidative stress has been implicated in the
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diseases such as glaucoma, retinopathy of prematurity,
macular degeneration, and uveitis.11 Although previous
ex vivo studies have reported oxidative damage in
keratoconic corneas, systemic oxidant and antioxidant
status were not investigated in patients with keratoconus
previously.4–6 The oxidative status of biological samples
is regarded as an indicator of oxidative stress and the
measurement of total oxidant status (TOS) and total
antioxidant status (TAS) are the most common
procedures to test for prediction of oxidative stress.10,11
Hence, the aim of the present study was to establish the
role of systemic oxidative stress in the pathogenesis of
keratoconus. For this purpose, we used the total oxidant
and antioxidant parameters instead of individual




The study was performed in adherence to the tenets of
the Declaration of Helsinki and the local ethics
committee approved the methodology. Written informed
consent was obtained from all participants. Twenty-five
patients with keratoconus (keratoconus group) and 25
age–sex-matched healthy subjects (control group) with
normal ophthalmological examination were enrolled in
this study.
Inclusion criteria for the keratoconus group were
corneal topography pattern consistent with keratoconus,
inferior–superior ratio on topographic map41.5, and at
least 18 years of age. Subjects with any of following
conditions were excluded from the study: smoking habit,
history of any other corneal pathology or surgery,
presence of systemic inflammation or systemic disease
(diabetes, uncontrolled hypertension, renal, or hepatic
dysfunction), and current anti-inflammatory or
antioxidant therapies.
All participants underwent a complete ophthalmic
examination including corrected visual acuity
measurement (Snellen charts), slit-lamp biomicroscopy
examination, applanation tonometry, and dilated
funduscopic examination with non-contactþ 90 D
lens.
Corneal topography (Oculus Pentacam, Oculus
Optikgerate GmbH, Wetzlar, Germany) was conducted
with undilated pupils under scotopic conditions by a
single experienced technician. Scans were taken in
automatic mode with proper quality. In bilateral cases,
eyes with more advanced stage of keratoconus (eyes with
a steeper maximum keratometry) were selected for
statistical analysis. Eyes were divided into groups
according to the maximum keratometry as follows: mild
(maximum Kr47 D), moderate (maximum K between
47–52 D), and severe (maximum KZ52 D) keratoconus.
Blood sampling
Five milliliters of peripheral venous blood was obtained
from all participants after overnight fasting in the
morning. The blood samples were collected into plain
red top blood collection tubes (without any solution) and
centrifuged at 5000 r.p.m. for 10 min. The serum layer
was separated and stored at  80 1C until needed for
analysis.
TOS measurement
The TOS of serum was determined using an automated
measurement method developed by Erel.12 In this
method; oxidants present in the sample oxidize the
ferrous ion-o-dianisidine complex to ferric ion.
The oxidation reaction is enhanced by the glycerol
molecules present in the reaction medium. The ferric
ion produced a colored complex with xylenol orange in
acidic solution. The color intensity, which is measured
spectrophotometrically, is proportional to the total
amount of oxidant molecules present in the sample.
The assay is calibrated with hydrogen peroxide,
and the results are expressed in terms of micromolar
hydrogen peroxide equivalents per liter (mmol H2O2
equivalent/l).12
TAS measurement
The TAS of the serum was determined using a novel
automated measurement method developed by Erel.10 In
this method, hydroxyl radical, which is the most potent
biological radical, is produced by the Fenton reaction and
reacts with the colorless substrate O-dianisidine to
produce the dianisyl radical, which is bright yellowish-
brown in color. Upon the addition of a serum sample, the
oxidative reactions initiated by the hydroxyl radicals
present in the reaction mix are suppressed by the
antioxidant components of the serum, preventing the
color change and thereby providing an effective measure
of the total antioxidant capacity of the serum.10 The
results were expressed as mmol Trolox equivalent/l.
Oxidative stress index
The percentage ratio of the total peroxide level to the TAS
was used as the oxidative stress index (OSI).13 The OSI
was calculated according to the following formula:13
OSI (arbitrary unit)¼TOS (mmol H2O2 Eq/l)/TAS
(mmol Trolox Eq/l) 100
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Sample size was determined at 92% power and 0.05
significance (95% confidence interval) level from
previous similar literature and was found to be 19
subjects per group using a software (PASS version 11.0.1,
NSCC, LLC, Park City, UT, USA). Statistical analysis was
performed with the Statistical Package for Social Sciences
software version 16.0 (SPSS Inc, Chicago, IL, USA). The
values were expressed as mean±standard error (SE).
Qualitative variables were analyzed using the w2 test.
Comparison of the quantitative data (TAS, TOS, and OSI
values) between two groups was performed by
Mann–Whitney U test. Kruskal–Wallis test was used to
compare differences among keratoconus severity groups
in terms of oxidative stress markers (TAS, TOS, and OSI
values). Spearman correlation coefficients were used to
analyze the association between maximum keratometry
and oxidative stress markers (TAS, TOS, and OSI values).
A P-value less than 0.05 was considered statistically
significant at 95% confidence interval.
Results
Twenty-five patients with keratoconus (keratoconus
group) and 25 age–sex matched healthy subjects (control
group) were included in the study. The keratoconus
group consisted of 12 (48%) male and 13 (52%) female
(mean age 26.4±1.7 years) and the control group
comprised 11 (44%) male and 14 (56%) female (mean age
26.6±1.7 years) (P40.05).
The serum TOS was found to be significantly higher in
the keratoconus group compared with that of the control
group (6.75±1.07 vs 4.28±0.34 mmol H2O2 equivalent/l,
P¼ 0.036), whereas serum TAS did not show significant
difference between the keratoconus and control groups
(0.71±0.05 vs 0.77±0.03 mmol Trolox equivalent/l,
P¼ 0.497) (Figures 1 and 2, respectively). Similar to the
serum TOS values, the OSI value was significantly higher
in the keratoconus group than in the control group
(3.08±1.49 vs 0.61±0.08 arbitrary units, P¼ 0.037)
(Figure 3).
Comparing the keratoconus severity groups (mild,
n¼ 4, moderate, n¼ 9, severe, n¼ 12), there were no
statistically significant differences in terms of TOS, TAS,
and OSI values (P40.05). Moreover, correlation analysis
did not show significant relations between maximum
keratometry and oxidative stress markers (P40.05).
Discussion
The molecular pathogenesis of keratoconus is poorly
understood and the role of oxidative stress is still being





























Figure 1 Total oxidant status (TOS) of serum in the control and
keratoconus groups. (Values are expressed as mean±standard































Figure 2 Total antioxidant status (TAS) levels of serum in the
control and keratoconus groups. (Values are expressed as























Figure 3 Oxidative stress index (OSI) values for the control and
keratoconus groups. (Values are expressed as mean±standard
error, *P¼ 0.037, Mann–Whitney U test).
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higher levels of oxidative byproducts that react with
cellular substrates, mitochondrial DNA damage, and
altered antioxidant enzymes in keratoconic corneas.14–17
Arnal et al5 reported that the total nitrite levels and lipid
peroxidation were significantly higher, whereas
antioxidant capacity and glutathione content were
significantly lower in keratoconic corneas when compared
with those of the healthy corneas. Similarly, extracellular
superoxide dismutase levels were found to be significantly
decreased in keratoconic corneas.8 Furthermore, it has
been suggested that oxidative stress induces activation of
tissue proteinases and degradation of proteinase inhibitors
that lead to progressive corneal thinning, a major hallmark
of keratoconus9,18 Kenney et al19 demonstrated reduced
levels of tissue inhibitor of matrix metalloproteinase 1 and
increased cathepsin V/L2 (a cysteine proteinase) and
catalase levels in keratoconic corneas.
Oxidative stress can be defined as an increase in
oxidants and/or a decrease in antioxidant capacity.20
Although previous ex vivo studies have focused on
alterations in oxidant and antioxidant components of
keratoconic corneas, systemic oxidative status of the
patients with keratoconus was not investigated
previously.4,5,21 To our knowledge, our study is the first
to determine oxidant and antioxidant status of the
patients with keratoconus by measuring serum TAS and
TOS levels.
The measurement of TAS practically represents the
cumulative action of antioxidants and their synergistic
interaction, which reflects the antioxidant status of the
organism.20 However, oxidant status and antioxidant
status should be measured simultaneously to assess
oxidative stress more exactly.20 Furthermore, redox
balance between oxidation and antioxidation can be
determined by the ratio percentage of the TOS to TAS,
regarded as OSI.13 We used an automated colorimetric
measurement method for TAS and TOS developed by
Erel, which has been found to be sensitive, reliable, and
reproducible.10,12,22
In the current study, serum TOS and OSI were found to
be significantly higher in patients with keratoconus
compared with those of the controls, although there was
no significant difference in terms of TAS between the
groups. These results might suggest that patients with
keratoconus are exposed to potent oxidative stress and
redox balance shifts toward oxidation, whereas
antioxidant defense seems to be unchanged in these
patients. Similarly, a number of clinical studies have
found that the tears of patients with keratoconus had
lower levels of glutathione (an antioxidant that
compensates increased oxidative stress), higher levels of
proteolytic activity, and overexpression of several matrix
metalloproteinases compared with those of the healthy
controls.23,24
In conclusion, although previous ex vivo studies have
provided evidence that local oxidative stress has a role
in the pathogenesis of keratoconus, this is the first
clinical study to evaluate the systemic oxidative and
antioxidative status of the patients with keratoconus.
The higher serum oxidant status and OSI indicate that
systemic oxidative stress might contribute to the
development of keratoconus, whereas our findings need
to be confirmed by further studies in a larger population.
Summary
What was known before:
K Previous ex vivo studies demonstrated oxidative damage
and alterations in antioxidant defenses in keratoconic
corneas. The systemic oxidative status of patients with
keratoconus was not investigated previously.
What this study adds:
K In patients with keratoconus, serum oxidant status and
oxidative stress index were significantly higher when
compared with those of the healthy controls. This study
revealed that systemic oxidative stress might be an
important predisposing factor for keratoconus.
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